Latest Headlines
-
Avance Clinical Welcomes Kelly Yang As Associate Director, Operations Taiwan
10/17/2024
Avance Clinical, a leading global contract research organization (CRO) specializing in advanced clinical research solutions for biotechs, is excited to announce the appointment of Kelly Yang as Associate Director, Operations Taiwan. Kelly brings over 15 years of experience in the pharmaceutical and clinical research industries, making her a valuable addition to Avance Clinical’s growing team.
-
Germfree Acquires Cleanroom Wall And Ceiling OEM Arcoplast
10/15/2024
Germfree, a pioneering leader in modular and mobile cleanroom infrastructure, equipment and services, today announced the acquisition of Arcoplast, maker of the leading seamless primary barrier cleanroom wall and ceiling system for Life Science applications and more. The acquisition will allow Germfree to offer comprehensive facility solutions from the ground up and follows 17 years of collaboration between the companies, during which Arcoplast has supplied architectural systems for Germfree installations at over 200 facilities globally.
-
AST Announces Additions To Business Development Team
10/9/2024
AST is pleased to welcome two new members to our business development team. Kacie Dennis (right) and Maximilian Kircher (left) joined our team last week and (literally) hit the ground running. They’re already en route to their first tradeshows with AST where, this week, Kacie will be in person at Meeting on the Mesa, and you can find Max in Italy at CPHI Worldwide.
-
Ascend Advanced Therapies Procures GENiSYS® C Isolated Filling Systems From AST For Gene Therapy Manufacturing
10/3/2024
AST, a leading provider of flexible aseptic filling systems, has announced the placement of a next-generation GENiSYS® C fill-finish system at the Ascend Advanced Therapies (Ascend) Alachua, FL facility. Ascend is a global gene to GMP gene therapy development partner with 58,500 square feet of recently acquired GMP manufacturing space in Alachua, a rapidly growing biotech hub and birthplace of AAV gene therapy. The new fully automated and isolated filling and closing line will be installed as part of the commercial infrastructure expansion of the Ascend Alachua facility.
-
CAI Appoints Sheena Dempsey As Chief Executive Officer
10/2/2024
CAI, a global professional services firm and trailblazer in operational readiness and excellence, today announced Sheena Dempsey as Chief Executive Officer (CEO). Dempsey is a widely respected and highly accomplished C-Suite executive with more than 25 years of expertise in global business transformation, sales and operations, P&L management and creating and nurturing high performing teams. In this role, she will lead CAI as a global partner in its ongoing commitment to ensuring client operational readiness through innovative methodologies and technology.
-
SK pharmteco And AaviGen Announce Strategic Partnership To Manufacture AaviGen's Lead Gene Therapy Product For Heart Failure
10/2/2024
SK pharmteco, a global contract development and manufacturing organization (CDMO) for small molecules and advanced therapies, and AaviGen GmbH, a preclinical stage biotechnology company focused on the development of curative gene therapies for cardiovascular and cardiopulmonary diseases, today announced a multi-year manufacturing agreement wherein SK pharmteco will be the preferred manufacturing partner for Aavigen’s lead gene therapy product AVG-101 for the treatment of heart failure.
-
Beckman Coulter Life Sciences Names Joe Fox President
10/1/2024
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation (NYSE: DHR), announces the appointment of Joe Fox as President of the company effective immediately.
-
SK pharmteco Invests $260 Million To Expand Global Small Molecule And Peptide Production
9/30/2024
SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new state-of-the-art facility in Sejong, South Korea.
-
HERMA US Inc. Partners With Norwalt Automation Group To Unveil Innovative Labeling Solutions At PackExpo
9/26/2024
The newly developed 211RHC labeling cell features the world’s smallest fully integrated servo gripper and performs up to 25% faster than comparable semi-automatic machines.
-
SK pharmteco And Cryoport Partner For Cell And Gene Therapy Logistics And BioServices
9/25/2024
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and SK pharmteco, a global contract development and manufacturing organization, today announced a strategic collaboration to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies.